Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Early Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (100.0%)Burosumab for CSHS
Early Phase 1
- Conditions
- Epidermal Nevus SyndromeCutaneous Skeletal Hypophosphatemia Syndrome (CSHS)
- Interventions
- First Posted Date
- 2019-06-21
- Last Posted Date
- 2022-03-07
- Lead Sponsor
- Laura Tosi
- Target Recruit Count
- 1
- Registration Number
- NCT03993821
- Locations
- 🇺🇸
Children's National Hospital, Washington, District of Columbia, United States
News
No news found